Showing 770 – 780 of 1304 results
-
Top 25 Most Influential Women in Mid Market M&A
Justine Chiou, a William Blair managing director with the investment banking team, was named to Mergers & Acquisitions 2021 Top 25 Most Influential Women in Mid-Market M&A.
-
Sartorius Stedim Biotech and Polyplus Transaction
William Blair acted as the exclusive financial advisor to Sartorius Group (XTRA:SRT) on its pending acquisition of Polyplus, for €2.4 billion, via its subsidiary Sartorius Stedim Biotech.
-
PDQ and Berkshire Partners Transaction
William Blair acted as the exclusive financial advisor to PDQ, a portfolio company of TA Associates, in connection with a significant growth investment from Berkshire Partners.
-
Corepoint Health and Rhapsody Health
William Blair acted as exclusive financial advisor to Corepoint Health (Corepoint), a portfolio company of Audax Group, in connection with its merger with Rhapsody Health, a portfolio company of HgCapital.
-
Service Express and Harvest Partners Transaction
William Blair acted as a financial advisor to Service Express Inc., a portfolio company of Pamlico Capital, in connection with its acquisition by Harvest Partners.
-
Hepberger Joins William Blair Healthcare Investment Banking
William Blair today announced the hiring of Rainer Hepberger as a managing director on the firm's healthcare investment banking team.
-
William Blair Hosts Students to Encourage STEM Careers
William Blair hosted a group of Chicago elementary school girls on February 13 for an interactive learning session about 3D printing run by nonprofit MakerGirl, which inspires study in science, technology, engineering, and math (STEM).
-
American Landscaping Partners and Shoreline Equity Partners Transaction
William Blair acted as the exclusive financial advisor to American Landscaping Partners, a portfolio company of Cold Bore Capital, in connection with its sale to Shoreline Equity Partners.
-
CELLect Horizons Moving the Needle in Hematological Malignancies
Explore the latest advancements in CAR-T therapies from William Blair’s Equity Research healthcare and biotechnology team. Discover how these next-generation therapies are transforming the treatment landscape for patients with liquid tumors.
-
Critical Process Systems Group and Exyte Transaction
William Blair acted as the exclusive financial advisor to Critical Process Systems Group (CPS Group), a portfolio company of Wynnchurch Capital, in connection with its sale to Exyte.